Sort
51,593 grants matching “hepatitis”
Project 1: Post-Shock Mesenteric Lymph and the 5-Lipoxygenase Pathway
$570,925Ernest E Moore · University Of Colorado Denver · P50 · FY2011 · GM
Project 1 - Cardiometabolic Injury due to VOCs
$570,837Aruni Bhatnagar Bhatnagar · University Of Louisville · P42 · FY2025 · ES
Clinical
$570,805Richard E Chaisson · Johns Hopkins University · P30 · FY2016 · AI
Pathogenesis of Liver Disease in Hepatitis
$570,762Scripps Research Institute · R01 · FY2005 · AI
RYGB Improves Metabolism by Interrupting the Gastric Adipose Tissue Axis
$570,736Naji N Abumrad · Vanderbilt University · R01 · FY2013 · DK
Candidate Genes Affecting Adolescent Metabolic Syndrome
$570,703Roy L Silverstein · Medical College Of Wisconsin · R01 · FY2011 · DK
Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing
$570,689Charles Yen Chiu · University Of California, San Francisco · R01 · FY2014 · HL
Quantitative MRI and Deep Learning Technologies for Classification of NAFLD
$570,640Holden H Wu · University Of California Los Angeles · U01 · FY2024 · EB
Effects of State Laws to Reduce Opioid Diversion on Transitions to Injection Drug Use and HIV/HCV Transmission
$570,636Julia B Dickson-Gomez · Medical College Of Wisconsin · R01 · FY2019 · DA
Role of liver fat and fibrosis in human CVD risk phenotypes.
$570,618Rohit Loomba · University Of California, San Diego · P01 · FY2021 · HL
Functional roles of Nrf2 and NQO1 genetic variants in hyperoxic lung injury-ARDS
$570,615Bhagavatula Moorthy · Baylor College Of Medicine · R01 · FY2014 · HL
Reducing HCV/HIV risks comparing two interventions
$570,582Robert E Booth · University Of Colorado Denver · R01 · FY2006 · DA
HCV Infection--Risk Factors for Progression
$570,559Harvard University (Sch Of Public Hlth) · R01 · FY2002 · CA
NCI ET-CTN with Phase i Emphasis at UPCI
$570,371Edward Chu · University Of Pittsburgh At Pittsburgh · UM1 · FY2015 · CA
Regulation of Lipolysis by Oxytocin
$570,337Evan D Rosen · Beth Israel Deaconess Medical Center · R01 · FY2023 · DK
Sleeping Beauty-Mediated Gene Therapy for Hemophilia
$570,317R Scott McIvor · Discovery Genomics, Inc. · R44 · FY2012 · HL
Clinical Translation of Deformation Compensation for Image-Guided Liver Surgery
$570,256Michael Ian Miga · Vanderbilt University · R01 · FY2011 · CA
Human neural precursor cell-mediated therapy in a viral model of demyelination
$570,252Thomas E Lane · University Of Utah · R01 · FY2015 · NS
Hormonal Regulation of Human CYP3A
$570,241Kenneth E. Thummel · University Of Washington · R01 · FY2016 · GM
Hormonal Regulation of Human CYP3A
$570,241Kenneth E. Thummel · University Of Washington · R01 · FY2014 · GM
Hormonal Regulation of Human CYP3A
$570,241Kenneth E. Thummel · University Of Washington · R01 · FY2015 · GM
Hormonal Regulation of Human CYP3A
$570,241Kenneth E. Thummel · University Of Washington · R01 · FY2017 · GM
Role of the Endothelium and Neutrophils in the Prothrombotic Nature of HIT
$570,104Mortimer Poncz · Children'S Hosp Of Philadelphia · R01 · FY2019 · HL
Dichloroacetate Kinetics, Metabolism and Toxicology
$570,056Peter W. Stacpoole · University Of Florida · R01 · FY2006 · ES
Role of liver fat and fibrosis in human CVD risk phenotypes.
$570,016Rohit Loomba · University Of California, San Diego · P01 · FY2020 · HL